Institute of Liver & Biliary Sciences

What Institute of Liver & Biliary Sciences does

Institute of Liver & Biliary Sciences (ILBS) is an autonomous super-specialty hospital and deemed university operated by the Government of the National Capital Territory of Delhi and located in New Delhi. Founded in 2009 and granted Deemed-to-be-University status by the UGC in 2011, it is India's first and only dedicated hospital for liver and biliary diseases, integrating patient care, postgraduate medical training (DM in Hepatology, M.Ch in HPB Surgery, PhD, postdoctoral courses), and translational research under one roof. The Institute serves hepatobiliary patients via direct OPD/IPD, telemedicine virtual OPD, community outreach programs (Project Prakash, Healthy Liver Healthy Delhi, LiHAB), and referrals from empanelled government health schemes (DGHS, ESI, CGHS) and corporate/TPA partners.

The Institute's clinical service line spans hepatology, liver and kidney transplantation (1,135 liver transplants and 315–341 kidney transplants to date), HPB surgery, nephrology, oncology, interventional radiology, and critical care. Clinical technology includes a Versa HD linear accelerator with SBRT/IGRT, a 128-slice time-of-flight PET-CT, Y-90 transarterial radioembolization (TARE) theranostics, and a cGMP-grade cell therapy manufacturing facility (ISO Class-6 clean room). The research platform combines a multi-omics stack—two HRMS Q Exactive Plus instruments, NextSeq/MiSeq sequencing, scRNA-seq, extracellular vesicle isolation, an Extracellular Vesicle Laboratory, a BSL-3 containment facility, and a CCSEA-registered ~15,000 sqft Center for Comparative Medicine—supporting biomarker discovery and pre-clinical drug development.

ILBS's revenue model blends regulated clinical fees under government health schemes and corporate empanelment with academic tuition and extramural research grants from ICMR, DBT, DST, SERB, BIRAC, CEFIPRA and international partners including INSERM/INRA (France) and the DBT-NIH Alliance. It holds WHO Collaborating Centre status for liver diseases and hosts the APASL School of Hepatology, drawing trainees from over 40 countries. Pricing is not publicly disclosed; the Institute also serves economically weaker sections at subsidized rates and is currently developing ILBS Phase II to expand academic, research, and clinical capacity.

Name

Institute of Liver & Biliary Sciences

Legal name

Institute of Liver & Biliary Sciences

Website

https://ilbs.in

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Institute of Liver & Biliary Sciences is a Delhi-based autonomous government institute and deemed university providing super-specialty clinical care, postgraduate training, and multi-omics research in liver and biliary diseases, serving patients across India and trainees from 40+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Clinical Services Revenue: Revenue from patient care services including outpatient consultations, inpatient admissions, transplant surgeries, diagnostic services, and therapeutic procedures. Services are provided under various government health schemes (DGHS, ESI, CGHS, Delhi Government Health Scheme) and empanelled corporate/insurance schemes.
2. Academic/Training Programs: Revenue from educational programs including DM in Hepatology, M.Ch in HPB Surgery, PhD courses, postdoctoral certificate courses, fellowships, nursing courses, and short-term training programs. Approved by Medical Council of India and UGC.
3. Government Grants: ILBS is an autonomous institute under GNCT of Delhi receiving government funding. Additional research funding from extramural grants by ICMR, DBT, DST, SERB, and international agencies.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

ILBS delivers super-specialty clinical care for liver, biliary, and pancreatic diseases including liver and kidney transplantation, hepatology, HPB surgery, oncology, nephrology, and radiology, supported by advanced radiation oncology and theranostics. It also operates as a deemed university offering DM Hepatology, M.Ch HPB Surgery, PhD, postdoctoral certificate courses, fellowships, and nursing programs, and runs translational research in multi-omics, extracellular vesicles, cell therapy, and BSL-3 certified containment research under one roof in New Delhi.

Product overview

Institute of Liver & Biliary Sciences (ILBS) operates as a specialized healthcare institution offering comprehensive liver and biliary disease management through multiple service channels. The institution provides direct medical services including Hepatology, Transplant Services (Liver and Kidney), Nephrology, HPB Surgery, Oncology, and various supporting specialties. Digital offerings include patient-facing mobile applications (HepCare, e-Yakrit, iLiverCare) for health monitoring, a Telemedicine Virtual OPD for remote consultations, and an Online Lab Report portal. The institution also runs community outreach programs including Project ILBS ECHO, Project Prakash, Project Empathy, and the Healthy Liver Healthy Delhi initiative. ILBS serves as a deemed university under Section 3 of UGC Act, integrating clinical care with academic training and research activities.

Differentiator

Problem solved

Functional benefit

Brands

• HepCare: Mobile health application for liver care management
• e-Yakrit
• iLiverCare
• Liver Gyan
• Li Hab

Products and services

• Hepatology Clinical Services Super-specialty hepatology clinical care including diagnosis and management of liver diseases such as cirrhosis, hepatitis, fatty liver disease, liver cancer, autoimmune hepatitis, Wilson's disease, biliary atresia, and acute liver failure for adult and pediatric patients.
• Liver Transplant Services Liver transplantation program including living donor and deceased donor liver transplants; 1,135+ liver transplants completed as a clinical service for patients with end-stage liver disease.
• Kidney Transplant and Renal Transplant Surgery Renal transplant and urology services including living donor, cadaveric, HIV-positive, ABO-incompatible, and paired kidney donations; 341 kidney transplants completed.
• HPB Surgery (Hepato-Pancreato-Biliary Surgery) Surgical management of diseases of the liver, pancreas, and biliary tract including complex HPB oncology and benign HPB disease surgery.
• Oncology (Liver and HPB Cancers) Oncology services for liver and hepatopancreaticobiliary cancers including radiation oncology with SBRT/IGRT on Versa HD Linear Accelerator, transarterial chemoembolization (TACE), transarterial radioembolization (TARE/Y-90), immunotherapy, and systemic therapy.
• Radiology and Interventional Radiology Radiology and interventional radiology services including 128-slice time-of-flight PET-CT imaging, Y-90 TARE with voxel-level dosimetry planning, TIPS, BRTO, PTBD, PCD, ablation therapy, ERCP, and image-guided interventions for liver disease.
• Laboratory Medicine and Diagnostic Services Diagnostic laboratory services including liver function tests, advanced multi-omics biomarker testing, and routine pathology with an online lab report portal accessible to patients.
• Telemedicine Virtual OPD WhatsApp-based virtual outpatient department service enabling remote patient consultations from any location (contact 9540947085).
• LiHAB Integrated Program for Alcohol-Related Liver Disease Integrated program for Alcohol Use Disorder (AUD) patients combining addiction treatment, lifestyle nutrition counseling, and liver disease management under one roof.
• HepCare Mobile Application Mobile healthcare application on Google Play Store for patient health management and liver disease tracking.
• e-Yakrit Mobile Application Mobile application for liver health monitoring and patient management, available on iOS and Android platforms.
• iLiverCare Mobile Application Mobile application for liver care calculator and health monitoring, available on Google Play Store.
• Online Lab Report Portal Web-based portal for patients to access their laboratory test results online.
• Liver Gyan Patient Education and Helpline Patient education program and liver health helpline (1800115354) providing awareness and information on liver diseases.
• DM in Hepatology Degree Program Super-specialty Doctorate of Medicine (DM) in Hepatology degree program approved by the Medical Council of India and UGC.
• M.Ch in HPB Surgery Degree Program Super-specialty Master of Chirurgiae (M.Ch) in Hepato-Pancreato-Biliary Surgery degree program approved by the Medical Council of India and UGC.
• PhD in Biomedical Sciences Doctor of Philosophy (PhD) program in Biomedical Sciences with UGC approval for full-time research scholars.
• Fellowship and Postdoctoral Certificate Courses Fellowships and postdoctoral certificate courses in hepatology, HPB surgery, transplant services, and related specialties for medical professionals.
• International Medical Observership and Training Programs International observership and hands-on training programs for medical professionals from 40+ countries including USA, Nepal, Saudi Arabia, Egypt, UAE, Germany, Denmark, New Zealand, Iraq, Armenia.
• APASL School of Hepatology Training Asian Pacific Association for Study of Liver (APASL) School of Hepatology training program hosted at ILBS, providing specialized hepatology training for medical professionals across the Asia-Pacific region.

Quantifiable outcome

• 1,287,677+ OPD patients served, 1,135 liver transplants, 315 kidney transplants (Phase I + Phase II combined: 341), 16,323 total surgeries, 195,029 endoscopy procedures
• +2 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

13 partnerships are on record, tiered core and minor.

• INSERM, FrancecoreStrategic or Co-development PartnerMetabolome and Metagenomics laboratory partnership with INSERM, France. Indo-French Node 'InFLeMin' supported by CEFIPRA/DST and INSERM for joint studies on liver diseases and gut microbiota.
• INRA FrancecoreStrategic or Co-development PartnerILBS-INRA (France) joint laboratory for studies on liver diseases and gut microbiota under Indo-French collaboration.
• DBT-NIH Alliance (USA)coreStrategic or Co-development PartnerIndo-US Laboratory for Human Immunology Project Consortium (HIPC) under DBT-NIH alliance. Collaborative immunology research program between India and USA.
• Asian Pacific Association for Study of Liver (APASL)coreStrategic or Co-development PartnerAPASL - School of Hepatology hosted at ILBS, providing specialized hepatology training programs for medical professionals across the Asia-Pacific region. APASL Trainee program operating at ILBS.
• CEFIPRA/DSTcoreStrategic or Co-development PartnerIndo-French joint research support through CEFIPRA/DST funding for collaborative liver disease research including InFLeMin node and joint studies.
• ICMR (India)coreStrategic or Co-development PartnerICMR-approved Centre for Advanced Research on Bioengineered In-vitro Liver Models; multiple ICMR-funded research projects (11 projects totalling Rs 9.5Cr). ICMR National Cancer Registry Programme through ICMR-NCDIR for hospital-based cancer registries.
• BIRACminorStrategic or Co-development PartnerBIRAC Funded program for establishing preclinical models for drug discovery at ILBS.
• DST (India)coreStrategic or Co-development PartnerDST-funded core Laboratory for Non-Transplant Therapeutic Strategies for Advanced Liver Disease; DST-FIST program for confocal microscopy facility; multiple DST-SERB funded research projects.
• IIT GuwahatiminorStrategic or Co-development PartnerICMR-approved Centre for Advanced Research on Bioengineered In-vitro Liver Models for Evaluation of Hepatotropic Infections and Therapeutics - collaboration with IIT Guwahati.
• Ayush (India)minorStrategic or Co-development PartnerILBS-Ayush Project on Pre-clinical Trials of Ayur Formulations for Fatty Liver Disorder (2 projects totalling Rs 2 Cr).
• WHO (World Health Organization)coreStrategic or Co-development PartnerWHO Collaborating Centre for Liver Diseases. Department of Psychiatry hosted national webinar on Prevention and Control of NAFLD and ALD in collaboration with WHO as part of WHOCC TOR obligations.
• DBT (India)coreStrategic or Co-development PartnerMultiple DBT-funded research projects (3 projects totalling Rs 3.1 Cr) including Global Star Call proposal for bacterial Exosomes Cargo targeting liver cancer.
• CGHS / DGHS / ESIcoreChannel Partner/ Reseller/ DistributorEmpanelled with Central Government Health Scheme (CGHS), Delhi Government Health Scheme (DGHS), and Employees' State Insurance (ESI) for cashless treatment of beneficiaries.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Medanta - The Medicity: India's leading multi-super-specialty hospital group with a strong liver transplant and hepatobiliary surgery program led by Dr. A.S. Soin. Directly comparable to ILBS on liver/kidney transplant volume, HPB surgery, and academic super-specialty training.
• Sir Ganga Ram Hospital: Large Delhi-based multi-specialty teaching hospital with a long-established hepatobiliary surgery and liver transplant program. Comparable to ILBS on tertiary hepatobiliary care, DNB/FNB teaching, and government scheme empanelment.
• Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS): Autonomous super-specialty teaching hospital and deemed university under the Government of Uttar Pradesh. Closest structural peer to ILBS in India on the model of autonomous state-funded super-specialty hospital + deemed university with high clinical and research throughput.
• Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh: Premier government super-specialty teaching hospital and deemed university under the Ministry of Health. Comparable to ILBS on the integrated hospital + deemed university + research model and on tertiary care scale across multiple specialties.
• Global Hospitals (Mumbai/Manipal): Pre-eminent hepatobiliary and multi-organ transplant specialty hospital network in India (now part of Manipal Hospitals). Closely comparable to ILBS in liver transplant volume, cadaveric transplant expertise, and high-end HPB surgery.

Broad incumbents

• Apollo Hospitals (Liver Transplant Program): India's largest private hospital chain with one of the country's busiest liver transplant programs at Indraprastha Apollo, Delhi. Comparable to ILBS on transplant volume and hepatology, but with broader multi-specialty portfolio and corporate/TPA revenue model.
• Fortis Healthcare (Hepatobiliary Program): Major private hospital network with established liver transplant and hepatobiliary surgery programs at Fortis Escorts and Fortis Memorial. Comparable to ILBS on tertiary liver care delivery but differentiated by commercial pricing and multi-city footprint.
• Max Healthcare (Liver Transplant Program): Delhi-NCR headquartered private hospital chain with active liver transplant and hepatology programs. Geographic and therapeutic overlap with ILBS in North India; differs in private/commercial model and broader multi-specialty offering.
• All India Institute of Medical Sciences (AIIMS), New Delhi: India's flagship government tertiary teaching hospital under central government. Comparable to ILBS in teaching hospital + research scale, but broader across all specialties; both compete for government scheme referrals and academic leadership in New Delhi.

Regional players

• Kokilaben Dhirubhai Ambani Hospital (Mumbai): Private Mumbai-based tertiary hospital with high-volume liver transplant program led by Dr. Subhash Rao. Therapeutic overlap with ILBS on liver transplantation and hepatobiliary surgery, but operates primarily in Western India.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/DelhiGovernmentDG
• Facebookfacebook.com/118075331602122
• Instagraminstagram.com/delhigovdigital
• LinkedInlinkedin.com/company/ilbs-india

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of Liver & Biliary Sciences